Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Endocrine 1CNS 1

Conditions

Keratosis, Actinic 15Cholangiocarcinoma 7Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 6Carcinoma, Basal Cell 6Skin Neoplasms 4Pancreatic Neoplasms 3Mesothelioma, Malignant 3Lung Neoplasms 3Bile Duct Neoplasms 3Tongue Neoplasms 2Pleural Diseases 2Neoplasms 2Mycosis Fungoides 2Leukoplakia, Oral 2Glioblastoma 2Esophageal Neoplasms 2Basal Cell Nevus Syndrome 2Barrett Esophagus 2Warts 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Skin Diseases 1Signs and Symptoms 1Sezary Syndrome 1Salivary Gland Neoplasms 1Retinoblastoma 1Rectal Neoplasms 1Precancerous Conditions 1Pleural Effusion, Malignant 1

Interventions

Temozolomide 109Magnetic Resonance Spectroscopy 52Bevacizumab 52Radiotherapy 44Irinotecan 27Blood Specimen Collection 19Surgical Procedures, Operative 16Radiation 15Aminolevulinic Acid 15Carboplatin 13fluorodopa F 18 12Nivolumab 12Radiotherapy, Intensity-Modulated 11Carmustine 11Radiosurgery 10Magnetic Resonance Imaging 10pembrolizumab 9Topotecan 9Specimen Handling 9Everolimus 9Erlotinib Hydrochloride 9Biopsy 9poly ICLC 8Surveys and Questionnaires 8Standard of Care 8Etoposide 8Drug Therapy 8Lomustine 7Filgrastim 7Cyclophosphamide 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Glioma × Photochemotherapy × Clear all
NCT01682746 2019-02-25

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

Medical College of Wisconsin

Phase 1 Completed
5 enrolled
CNSEndocrineSarcoma

Astrocytoma, Brain Neoplasms, Chordoma, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Oligodendroglioma, Pituitary Neoplasms, Germinoma, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡